Vise Technologies Inc. Makes New $543,000 Investment in Envista Holdings Corporation $NVST

Vise Technologies Inc. bought a new stake in shares of Envista Holdings Corporation (NYSE:NVST) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 27,769 shares of the company’s stock, valued at approximately $543,000.

A number of other hedge funds have also recently made changes to their positions in NVST. Envestnet Asset Management Inc. raised its stake in Envista by 55.7% during the first quarter. Envestnet Asset Management Inc. now owns 200,708 shares of the company’s stock valued at $3,464,000 after buying an additional 71,828 shares during the last quarter. New York State Common Retirement Fund increased its holdings in shares of Envista by 8.1% during the first quarter. New York State Common Retirement Fund now owns 450,101 shares of the company’s stock valued at $7,769,000 after acquiring an additional 33,855 shares in the last quarter. CWM LLC boosted its stake in Envista by 309.7% in the 1st quarter. CWM LLC now owns 25,928 shares of the company’s stock worth $448,000 after purchasing an additional 19,600 shares in the last quarter. Allianz Asset Management GmbH grew its position in Envista by 103.4% during the 1st quarter. Allianz Asset Management GmbH now owns 425,485 shares of the company’s stock valued at $7,344,000 after purchasing an additional 216,350 shares during the last quarter. Finally, Homestead Advisers Corp grew its position in Envista by 34.9% during the 1st quarter. Homestead Advisers Corp now owns 294,400 shares of the company’s stock valued at $5,081,000 after purchasing an additional 76,100 shares during the last quarter.

Analyst Ratings Changes

Several brokerages have recently issued reports on NVST. Stifel Nicolaus set a $25.00 target price on shares of Envista in a research note on Thursday, October 30th. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 15th. Evercore ISI reissued an “outperform” rating on shares of Envista in a report on Friday, October 31st. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 1st. Finally, Mizuho set a $19.00 price target on shares of Envista in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $21.33.

Envista Trading Down 2.6%

NYSE NVST opened at $19.37 on Friday. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $22.68. The company has a 50 day moving average price of $20.30 and a 200 day moving average price of $19.68. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $3.18 billion, a PE ratio of 60.52, a price-to-earnings-growth ratio of 1.09 and a beta of 1.05.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Envista had a net margin of 2.11% and a return on equity of 4.84%. The business had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. During the same period in the previous year, the company earned $0.12 earnings per share. The business’s revenue for the quarter was up 11.5% on a year-over-year basis. As a group, sell-side analysts forecast that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.